Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Should You Buy Blue Owl Stock for Income at a Low Valuation?
Should You Buy Blue Owl Stock for Income at a Low Valuation?

Blue Owl Capital Inc. OWL offers a standout income profile, with a 90 cents per share annual dividend that equates to roughly a 10.65% yield. The company most recently declared a quarterly dividend

BHP Advances Copper Strategy: Can It Unlock Bigger Returns?
BHP Advances Copper Strategy: Can It Unlock Bigger Returns?

BHP Group Limited BHP is reshaping its growth strategy around commodities with durable, long-term demand. Copper sits at the core of this shift, while potash is emerging as a complementary pillar

Do Options Traders Know Something About Afya Stock We Don't?
Do Options Traders Know Something About Afya Stock We Don't?

Investors in Afya Limited AFYA need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $2.50 Call had some of the highest implied

Robinhood vs. Schwab: Which Investing Platform is the Smarter Bet Now?
Robinhood vs. Schwab: Which Investing Platform is the Smarter Bet Now?

With the investing landscape changing at a rapid pace, Robinhood Markets HOOD and Charles Schwab SCHW have emerged as two major players in online brokerage. While both are seeking to capture a

Aehr Test Systems (AEHR) is a Great Momentum Stock: Should You Buy?
Aehr Test Systems (AEHR) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Here's Why Powell Industries (POWL) is a Great Momentum Stock to Buy
Here's Why Powell Industries (POWL) is a Great Momentum Stock to Buy

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Tokyo Electron Ltd. (TOELY) Is Up 16.55% in One Week: What You Should Know
Tokyo Electron Ltd. (TOELY) Is Up 16.55% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Here's Why Mitsubishi Electric Corporation (MIELY) is a Great Momentum Stock to Buy
Here's Why Mitsubishi Electric Corporation (MIELY) is a Great Momentum Stock to Buy

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Howmet (HWM) is a Great Momentum Stock: Should You Buy?
Howmet (HWM) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

HSBC (HSBC) Is Up 6.93% in One Week: What You Should Know
HSBC (HSBC) Is Up 6.93% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

What Makes Pebblebrook Hotel (PEB) a Strong Momentum Stock: Buy Now?
What Makes Pebblebrook Hotel (PEB) a Strong Momentum Stock: Buy Now?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Planet Labs vs. Snowflake: Which AI Data Stock Has an Edge Now?
Planet Labs vs. Snowflake: Which AI Data Stock Has an Edge Now?

Artificial Intelligence (AI) is reshaping the software landscape, redefining categories and competitive dynamics. Per The Business Research Company, the AI software market is projected to grow to

3 Reasons Why Growth Investors Shouldn't Overlook Ambev (ABEV)
3 Reasons Why Growth Investors Shouldn't Overlook Ambev (ABEV)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Is MasterCard (MA) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is MasterCard (MA) a Solid Growth Stock? 3 Reasons to Think "Yes"

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the treatment of moderate-to-severe eosinophilic asthma. KYMR shares rose 4%

J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook
J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook

Johnson & Johnson’s JNJ first-quarter 2026 earnings came in at $2.70 per share, which beat the Zacks Consensus Estimate of $2.67. Earnings declined 2.5% from the year-ago period.

Adjusted earnings

Can TruBridge (TBRG) Run Higher on Rising Earnings Estimates?
Can TruBridge (TBRG) Run Higher on Rising Earnings Estimates?

TruBridge (TBRG) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since

MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer

Merck MRK and its Japanese partner Daiichi Sankyo announced that the FDA has accepted the biologics license application (BLA) seeking approval for ifinatamab deruxtecan (I-DXd), a B7-H3-directed DXd

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?
Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Royalty Pharma